Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
In the current era, the antithrombotic treatment of patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) includes standard aspirin, and one of the potent P2Y<sub>12</sub> inhibitors ticagrelor or prasugrel. The optimal timing of ticagrelor has not been adequately stu...
Main Authors: | Cyril Camaro, Peter Damman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2578 |
Similar Items
-
Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond
by: Pablo Díez-Villanueva, et al.
Published: (2023-07-01) -
Long-term follow-up of antithrombotic management patterns in acute coronary syndrome patients
by: Fatih Sinan Ertaş, et al.
Published: (2018-04-01) -
CORONARY ANGIOGRAPHY FOLLOWING CARDIAC ARREST WITHOUT ST-SEGMENT ELEVATION: A MULTICENTER STUDY.
by: Aman Sinha
Published: (2023-12-01) -
ECG patterns suggestive of high-risk coronary anatomy in non-ST-segment elevation acute coronary syndrome – an analysis of real-world patients
by: Natalia Gołąbek, et al.
Published: (2023-10-01) -
Association between clinical parameters and ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
by: Ramūnas Unikas, et al.
Published: (2016-01-01)